Managing type 2 diabetes effectively requires a combination of the right medication, lifestyle changes, and continuous monitoring. GLIDAPA TENMET 500, a powerful triple-combination tablet containing Dapagliflozin (10 mg), Teneligliptin (20 mg), and Metformin Hydrochloride (500 mg), is designed to provide comprehensive glycemic control for individuals suffering from type 2 diabetes mellitus. This advanced formulation works through multiple mechanisms to regulate blood sugar levels, improve insulin sensitivity, and reduce glucose production, making it an ideal solution for patients who require combination therapy. How GLIDAPA TENMET 500 Works GLIDAPA TENMET 500 combines three well-established antidiabetic agents, each targeting different pathways: Dapagliflozin works by inhibiting SGLT2 receptors in the kidneys, promoting the excretion of excess glucose through urine. Teneligliptin increases incretin hormone levels, which stimulate insulin secretion and decrease glucagon release after meals. Metformin Hydrochloride reduces hepatic glucose production and improves insulin sensitivity in peripheral tissues. Together, this triple-action formula ensures better blood sugar control throughout the day, especially for patients with uncontrolled diabetes on monotherapy. Uses of GLIDAPA TENMET 500 GLIDAPA TENMET 500 is primarily prescribed for: Management of Type 2 Diabetes Mellitus Patients with inadequate glycemic control on dual therapy Reducing fasting and postprandial blood glucose levels Improving insulin sensitivity Supporting weight management in diabetic patients It is usually recommended along with a proper diet and regular exercise for optimal results. Key Benefits of GLIDAPA TENMET 500 1. Triple Mechanism Action Unlike single or dual therapy drugs, this combination provides a three-way approach to diabetes control, targeting different physiological processes. 2. Effective Blood Sugar Control It helps maintain stable glucose levels throughout the day, red